TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 1 | 4 | 13 | 7 | 33 | 3 | 10 |
| P | %wins | 50 | 50 | 100 | 100 | 100 | 50 | 75 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/4/10 14:03 | 12/30/09 | CUR | Neuralstem, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Garr Richard | MD | O | CEO | P | 312 | 1.65 | 0 | 189 | 15 | 1,413 | D | -51 | 8 | 53 | 20 | -1 | 1 | 3 | 8 | 3 | 9 | 2 | 12 | 40 | 18 |
7/7/08 16:03 | 7/7/08 | CUR | Neuralstem, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Garr Richard | MD | DO | CEO,P | P | 70 | 1.42 | 0 | 49 | 4 | 1,424 | D | -51 | -60 | -46 | 1 | -14 | -4 | -7 | -1 | -1 | 23 | 1 | 26 | -13 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |